This product is lyophilized and requires reconstitution. It comes with a home kit.

Retatrutide is a next-generation triple agonist peptide that activates the GLP-1, GIP, and glucagon receptors, making it one of the most advanced therapies for weight management and metabolic optimization. By targeting multiple pathways that regulate appetite, glucose control, and energy expenditure, Retatrutide supports greater fat reduction and improved metabolic health compared to single- or dual-agonist medications.

Benefits

Promotes significant and sustained weight loss
Improves insulin sensitivity and glucose regulation
Reduces appetite and cravings while supporting satiety
May increase energy expenditure and metabolic rate
Supports cardiometabolic and liver health

Estimated duration: 12–14 weeks following standard titration: 0.5mg weekly for weeks 1-4, 1mg weekly for weeks 5-8, 1.5mg weekly for weeks 9-12, 2mg+ weekly for weeks ongoing based on dosing protocol

Protocols generally begin at a lower weekly dose and increase gradually over time based on individual response and tolerance.

Initial phase: lower weekly dosing
Mid-phase: gradual increase
Advanced phase: higher individualized dosing ranges

Estimated duration is based on dosing protocol, please check patient portal and double check your protocol.

https://patients.outfitmd.com/portal/